Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation

NCT00620633 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndrome

Interventions

BIOLOGICAL: WT1-sensitized T cells

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]